Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

5α-reductase inhibitors for hair loss can cause mild, reversible sexual side effects in some men.

Finasteride may be linked to more psychiatric issues than dutasteride, but a definite cause isn't proven.

Finasteride mildly affects semen but is reversible; dutasteride has stronger effects with incomplete recovery.

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

Finasteride can cause melasma, especially in people with darker skin.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Finasteride can cause melasma, especially in people with darker skin.

Finasteride can cause melasma, especially in people with darker skin.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Dutasteride 0.5 mg/day is the most effective treatment for male pattern hair loss.